Skip to content

Opioid free analgesia in breast surgeries

Role of USG guided thoracic truncal block in opioid free anesthesia and analgesia for breast oncosurgeries.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024594
Enrollment
20
Registered
2020-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: USG GUIDED THORACIC TRUNCAL BLOCK: USG GUIDED THORACIC TRUNCAL BLOCK 25 ML TOTAL LOCAL ANESTHTIC AGENT Control Intervention1: control group: control group will recieve fentanyl 2 mcg /

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: FEMALES UNDERGOING BREAST ONCOSURGERIES ASA I & ASA II FEMALES GIVING VALID CONSENT

Exclusion criteria

Exclusion criteria: Patient refusal Patients belonging to ASA grade 3 and grade 4 Patients with difficult airways Patients with history of drug allergy Patients with localized skin infections, hemorrhagic diathesis.

Design outcomes

Primary

MeasureTime frame
1)To analyze and compare intra operative anesthetic and analgesic properties of usg guided thoracic truncal block with control group 2)To access postoperative analgesic efficacy of usg guided thoracic truncal block using vas score and rescue analgesia as compared to control group Timepoint: 24 HRS

Secondary

MeasureTime frame
1)To compare intraoperative consumption of anesthetic agents in test group and control group 2)To compare intraoperative and postoperative consumption of analgesic agents Timepoint: 24 HRS

Countries

India

Contacts

Public ContactDr Ujjwalraj Dudhedia

Dr. L H Hiranandani Hospital

ujjwalraj9775@gmail.com9022801230

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026